Acute rheumatic fever and rheumatic heart disease

Nature Reviews Disease Primers

Volumn 2, Issue , 2016, Pages

  Carapetis, Jonathan R ^a,b   Beaton, Andrea ^c   Cunningham, Madeleine W ^d   Guilherme, Luiza ^e,f   Karthikeyan, Ganesan ^g   Mayosi, Bongani M ^h   Sable, Craig ^c   Steer, Andrew ^i,j   Wilson, Nigel ^k,l   Wyber, Rosemary ^a   Zühlke, Liesl ^h,m  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY   (Brazil)

^g ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^k STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^l UNIVERSITY OF AUCKLAND   (New Zealand)

^m UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; STREPTOCOCCUS VACCINE; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFECTIVE AGENT;

AGE; CARDITIS; CHOREA MINOR; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; GLOBAL DISEASE BURDEN; HEART SURGERY; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK FACTOR; SCREENING TEST; SECONDARY PREVENTION; SEX; STREPTOCOCCUS GROUP A; TREATMENT INDICATION; VASCULAR ENDOTHELIUM; ADULT; AUTOIMMUNITY; CHILD; COMPLICATION; DRUG EFFECTS; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; PATHOGENICITY; PHARYNGITIS; PRESCHOOL CHILD; PROCEDURES; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ADULT; ANTI-BACTERIAL AGENTS; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PHARYNGITIS; PRIMARY PREVENTION; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 85019463595     PISSN: None     EISSN: 2056676X     Source Type: Journal    
DOI: 10.1038/nrdp.2015.84     Document Type: Review

References (262)

1. Gewitz, M. H., et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: A scientific statement from the American Heart Association. Circulation 131, 1806-1818 (2015
2. Denny, F. W., Wannamaker, L. W., Brink, W. R., Rammelkamp, C. H. Jr & Custer, E. A. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J. Am. Med. Assoc. 143, 151-153 (1950
3. Stollerman, G. H., Rusoff, J. H., Hirschfeld, I. Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G. N. Engl. J. Med. 252, 787-792 (1955
4. Carapetis, J. R. The stark reality of rheumatic heart disease. Eur. Heart J. 36, 1070-1073 (2015
5. Quinn, R. W. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, scarlet fever: The decline of rheumatic fever. Rev. Infect. Dis. 11, 928-953 (1989
6. Carapetis, J. R., Steer, A. C., Mulholland, E. K., Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685-694 (2005
7. Murray, C. J., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223 (2012
8. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117-171 (2015
9. Global Burden of Disease Study 2013 Collaborators. Global, regional, national incidence, prevalence, years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743-800 (2015
10. Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K., Condon, J. R. Acute rheumatic fever and rheumatic heart disease: Incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 128, 492-501 (2013
11. Parnaby, M. G., Carapetis, J. R. Rheumatic fever in indigenous Australian children. J. Paediatr. Child Health 46, 527-533 (2010
12. Rothenbuhler, M., et al. Active surveillance for rheumatic heart disease in endemic regions: A systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob. Health 2, e717-e726 (2014
13. Yacoub Wasef, S. Z. Gender differences in systemic lupus erythematosus. Gend. Med. 1, 12-17 (2004
14. Diao, M., et al. Pregnancy in women with heart disease in sub-Saharan Africa. Arch. Cardiovasc. Dis. 104, 370-374 (2011
15. Say, L., et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob. Health 2, e323-e333 (2014
16. Soma-Pillay, P., MacDonald, A. P., Mathivha, T. M., Bakker, J. L., Mackintosh, M. O. Cardiac disease in pregnancy: A 4-year audit at Pretoria Academic Hospital. S. Afr. Med. J. 98, 553-556 (2008
17. Sawhney, H., et al. Maternal and perinatal outcome in rheumatic heart disease. Int. J. Gynaecol. Obstetr. 80, 9-14 (2003
18. Steer, A. C., Carapetis, J. R., Nolan, T. M., Shann, F. Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors. J. Paediatr. Child Health 38, 229-234 (2002
19. Brown, A., McDonald, M. I., Calma, T. Rheumatic fever and social justice. Med. J. Aust. 186, 557-558 (2007
20. Riaz, B. K., et al. Risk factors of rheumatic heart disease in Bangladesh: A case-control study. J. Health Popul. Nutr. 31, 70-77 (2013
21. Quinn, R. W. Epidemiology of group A streptococcal infections-their changing frequency and severity. Yale J. Biol. Med. 55, 265-270 (1982
22. Jaine, R., Baker, M., Venugopal, K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr. Infect. Dis. J. 30, 315-319 (2011
23. Okello, E., et al. Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda. PLoS ONE 7, e43917 (2012
24. Carapetis, J. R., Currie, B. J. Rheumatic fever in a high incidence population: The importance of monoarthritis and low grade fever. Arch. Dis. Child 85, 223-227 (2001
25. Gordis, L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N. Engl. J. Med. 289, 331-335 (1973
26. Bach, J. F., et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 347, 644-648 (1996
27. Nordet, P., Lopez, R., Duenas, A., Sarmiento, L. Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience. Cardiovasc. J. Afr. 19, 135-140 (2008
28. Omurzakova, N. A., et al. High incidence of rheumatic fever and rheumatic heart disease in the republics of Central Asia. Int. J. Rheum. Dis. 12, 79-83 (2009
29. Ben-Pazi, H., Stoner, J. A., Cunningham, M. W. Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea. PLoS ONE 8, e73516 (2013
30. Brimberg, L., et al. Behavioral, pharmacological, immunological abnormalities after streptococcal exposure: A novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 37, 2076-2087 (2012
31. Cox, C. J., et al. Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: Implications in human disease. J. Immunol. 191, 5524-5541 (2013
32. Cunningham, M. W. Rheumatic fever, autoimmunity, molecular mimicry: The streptococcal connection. Int. Rev. Immunol. 33, 314-329 (2014
33. Ellis, N. M. J., Li, Y., Hildebrand, W., Fischetti, V. A., Cunningham, M. W. T cell mimicry and epitope specificity of crossreactive T cell clones from rheumatic heart disease. J. Immunol. 175, 5448-5456 (2005
34. Fae, K. C., et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 176, 5662-5670 (2006
35. Galvin, J. E., Hemric, M. E., Ward, K., Cunningham, M. W. Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: Implications in rheumatic heart disease. J. Clin. Invest. 106, 217-224 (2000
36. Husby, G., van de Rijn, I., Zabriskie, J. B., Abdin, Z. H., Williams, R. C. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J. Exp. Med. 144, 1094-1110 (1976
37. Kirvan, C. A., Cox, C. J., Swedo, S. E., Cunningham, M. W. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J. Immunol. 178, 7412-7421 (2007
38. Kirvan, C. A., Swedo, S. E., Heuser, J. S., Cunningham, M. W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9, 914-920 (2003
39. Kirvan, C. A., Swedo, S. E., Kurahara, D., Cunningham, M. W. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 39, 21-29 (2006
40. Krisher, K., Cunningham, M. W. Myosin: A link between streptococci and heart. Science 227, 413-415 (1985
41. Lehmann, P. V., Forsthuber, T., Miller, A., Sercarz, E. E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155-157 (1992
42. Shikhman, A. R., Cunningham, M. W. Immunological mimicry between N-acetyl-beta-d-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J. Immunol. 152, 4375-4387 (1994
43. Swerlick, R. A., Cunningham, M. W., Hall, N. K. Monoclonal antibodies cross-reactive with group A streptococci and normal and psoriatic human skin. J. Invest. Dermatol. 87, 367-371 (1986
44. Stollerman, G. H. Rheumatic fever in the 21st century. Clin. Infect. Dis. 33, 806-814 (2001
45. Veasy, L. G., et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113, 168-172 (2004)
46. McDonald, M., Currie, B. J., Carapetis, J. R. Acute rheumatic fever: A chink in the chain that links the heart to the throat Lancet Infect. Dis. 4, 240-245 (2004
47. Bessen, D. E., et al. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J. Infect. Dis. 182, 1109-1116 (2000
48. Erdem, G., et al. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: Differences from the continental United States. Clin. Infect. Dis. 45, e20-e24 (2007
49. Smeesters, P. R., et al. Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape. PLoS ONE 1, e10 (2006
50. Steer, A. C., et al. Acute rheumatic fever and rheumatic heart disease in Fiji: Prospective surveillance, 2005-2007. Med. J. Aust. 190, 133-135 (2009
51. Potter, E. V., et al. Relationship of acute rheumatic fever to acute glomerulonephritis in Trinidad. J. Infect. Dis. 125, 619-625 (1972
52. Zuhlke, L., et al. Characteristics, complications, gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study). Eur. Heart J. 36, 1115-1122 (2015
53. Towers, R. J., et al. Extensive diversity of Streptococcus pyogenes in a remote human population reflects global-scale transmission rather than localised diversification. PLoS ONE 8, e73851 (2013
54. Bryant, P. A., Robins-Browne, R., Carapetis, J. R., Curtis, N. Some of the people, some of the time. Susceptibility to acute rheumatic fever. Circulation 119, 742-753 (2009
55. Messias Reason, I. J., Schafranski, M. D., Jensenius, J. C., Steffensen, R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum. Immunol. 67, 991-998 (2006
56. Ramasawmy, R., et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin. Vaccine Immunol. 15, 932-936 (2008
57. Messias-Reason, I. J., Schafranski, M. D., Kremsner, P. G., Kun, J. F. Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin. Exp. Immunol. 157, 395-399 (2009
58. Berdeli, A., Celik, H. A., Ozyrek, R., Dogrusoz, B., Aydin, H. H. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J. Mol. Med. (Berl.) 83, 535-541 (2005
59. Yee, A. M., Phan, H. M., Zuniga, R., Salmon, J. E., Musher, D. M. Association between FcRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 30, 25-28 (2000
60. Settin, A., Abdel-Hady, H., El-Baz, R., Saber, I. Gene polymorphisms of TNF-308, IL-10-1082, IL-6-174, IL-1RaVNTR related to susceptibility and severity of rheumatic heart disease. Pediatr. Cardiol. 28, 363-371 (2007
61. Azevedo, P. M., et al. Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine 49, 109-113 (2010
62. Hernndez-Pacheco, G., et al. Tumor necrosis factor-promoter polymorphisms in Mexican patients with rheumatic heart disease. J. Autoimmun. 21, 59-63 (2003
63. Ramasawmy, R., et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-with clinical outcomes of rheumatic fever. Mol. Immunol. 44, 1873-1878 (2007
64. Sallakci, N., et al. TNF G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF production. J. Autoimmun. 25, 150-154 (2005
65. Kamal, H., et al. Transforming growth factor-1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt. Acta Cardiol. 65, 177-183 (2010
66. Chou, H. T., Chen, C. H., Tsai, C. H., Tsai, F. J. Association between transforming growth factor-1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am. Heart J. 148, 181-186 (2004
67. Dzgn, N., Duman, T., Haydardedeoglu, F. E., Tutkak, H. Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens 74, 539-542 (2009
68. Maharaj, B., Hammond, M. G., Appadoo, B., Leary, W. P., Pudifin, D. J. HLA-A, B, DR, DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 76, 259-261 (1987
69. Monplaisir, N., Valette, I., Bach, J. F. HLA antigens in 88 cases of rheumatic fever observed in Martinique. Tissue Antigens 28, 209-213 (1986
70. Donadi, E. A., Smith, A. G., Louzada-Jnior, P., Voltarelli, J. C., Nepom, G. T. HLA class I and class II profiles of patients presenting with Sydenham's chorea. J. Neurol. 247, 122-128 (2000
71. Ayoub, E. M., Barrett, D. J., Maclaren, N. K., Krischer, J. P. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J. Clin. Invest. 77, 2019-2026 (1986
72. Hernndez-Pacheco, G., et al. MHC class II alleles in Mexican patients with rheumatic heart disease. Int. J. Cardiol. 92, 49-54 (2003
73. Jhinghan, B., et al. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 27, 172-178 (1986
74. Ozkan, M., et al. HLA antigens in Turkish race with rheumatic heart disease. Circulation 87, 1974-1978 (1993
75. Anastasiou-Nana, M. I., Anderson, J. L., Carlquist, J. F., Nanas, J. N. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: A search for immune response factors. Am. Heart J. 112, 992-997 (1986
76. Rajapakse, C. N., Halim, K., Al-Orainey, I., Al-Nozha, M., Al-Aska, A. K. A genetic marker for rheumatic heart disease. Br. Heart J. 58, 659-662 (1987
77. Guilherme, L., Weidenbach, W., Kiss, M. H., Snitcowdky, R., Kalil, J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 83, 1995-1998 (1991
78. Visentainer, J. E., et al. Association of HLA-DR7 with rheumatic fever in the Brazilian population. J. Rheumatol. 27, 1518-1520 (2000
79. Gudez, Y., et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99, 2784-2790 (1999
80. Stanevicha, V., et al. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res. Ther. 5, R340-R346 (2003
81. Olmez, U., et al. Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Scand. J. Rheumatol. 22, 49-52 (1993
82. Guilherme, L., Khler, K. F., Kalil, J. Rheumatic heart disease: Mediation by complex immune events. Adv. Clin. Chem. 53, 31-50 (2011
83. Yoshinoya, S., Pope, R. M. Detectioin of immune complexes in acute rheumatic fever and their relationship to HLA-B5. J. Clin. Invest. 65, 136-145 (1980
84. Kaplan, M. H., Bolande, R., Ratika, L., Blair, J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. N. Engl. J. Med. 271, 637 (1964
85. Roberts, S., et al. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J. Infect. Dis. 183, 507-511 (2001
86. Greenfield, J. G., Wolfson, J. M. The pathology of Sydenham's chorea. Lancet 2, 603-606 (1922
87. Quinn, A., Kosanke, S., Fischetti, V. A., Factor, S. M., Cunningham, M. W. Induction of autoimmune valvular heart disease by recombinant streptococcal M protein. Infect. Immun. 69, 4072-4078 (2001
88. Taranta, A., Stollerman, G. H. The relationship of Sydenham's chorea to infection with group A streptococci. Am. J. Med. 20, 170-175 (1956
89. Meador-Woodruff, J. H., et al. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5, 231-242 (1991
90. Lotan, D., et al. Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats. Brain Behav. Immun. 38, 249-262 (2014
91. Hoffman, K. L., Hornig, M., Yaddanapudi, K., Jabado, O., Lipkin, W. I. A murine model for neuropsychiatric disorders associated with group A-hemolytic streptococcal infection. J. Neurosci. 24, 1780-1791 (2004
92. Perlmutter, S. J., et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354, 1153-1158 (1999
93. Garvey, M. A., Snider, L. A., Leitman, S. F., Werden, R., Swedo, S. E. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J. Child Neurol. 20, 424-429 (2005
94. Barash, J., Margalith, D., Matitiau, A. Corticosteroid treatment in patients with Sydenham's chorea. Pediatr. Neurol. 32, 205-207 (2005
95. Cardoso, F., Maia, D., Cunningham, M. C., Valenca, G. Treatment of Sydenham chorea with corticosteroids. Mov. Disord. 18, 1374-1377 (2003
96. Fusco, C., Ucchino, V., Frattini, D., Pisani, F., Della Giustina, E. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea. Eur. J. Paediatr. Neurol. 16, 373-378 (2012
97. Paz, J. A., Silva, C. A., Marques-Dias, M. J. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr. Neurol. 34, 264-269 (2006
98. Walker, A. R., et al. Rheumatic chorea: Relationship to systemic manifestations and response to corticosteroids. J. Pediatr. 151, 679-683 (2007
99. Yaddanapudi, K., et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry 15, 712-726 (2009
100. Lotan, D., Cunningham, M., Joel, D. Antibiotic treatment attenuates behavioral and neurochemical changes induced by exposure of rats to group a streptococcal antigen. PLoS ONE 9, e101257 (2014
101. Cunningham, M. W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13, 470-511 (2000
102. Zabriskie, J. B. Mimetic relationships between group A streptococci and mammalian tissues. Adv. Immunol. 7, 147-188 (1967
103. Zabriskie, J. B., Freimer, E. H. An immunological relationship between the group A streptococcus and mammalian muscle. J. Exp. Med. 124, 661-678 (1966
104. Zabriskie, J. B., Hsu, K. C., Seegal, B. C. Heart-reactive antibody associated with rheumatic fever: Characterization and diagnostic significance. Clin. Exp. Immunol. 7, 147-159 (1970
105. Cunningham, M. W. Streptococcus and rheumatic fever. Curr. Opin. Rheumatol 24, 408-416 (2012
106. Goldstein, I., Halpern, B., Robert, L. Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart valve. Nature 213, 44-47 (1967
107. Dudding, B. A., Ayoub, E. M. Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J. Exp. Med. 128, 1081-1098 (1968
108. McNamara, C., et al. Coiled-coil irregularities and instabilities in group A streptococcus M1 are required for virulence. Science 319, 1405-1408 (2008
109. Ellis, N. M. J., et al. Priming the immune system for heart disease: A perspective on group A streptococci. J. Infect. Dis. 202, 1059-1067 (2010
110. Gorton, D. E., et al. Cardiac myosin epitopes for monitoring progression of rheumatic fever. Pediatr. Infect. Dis. J. 30, 1015-1016 (2011
111. Cunningham, M. W., Antone, S. M., Smart, M., Liu, R., Kosanke, S. Molecular analysis of human cardiac myosin-cross-reactive B-A nd T-cell epitopes of the group A streptococcal M5 protein. Infect. Immun. 65, 3913-3923 (1997
112. Cunningham, M. W., et al. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J. Immunol. 143, 2677-2683 (1989
113. Faé, K. C., et al. CXCL9/MIG mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients. Inflammation 36, 800-811 (2013
114. Dale, J. B., Penfound, T. A., Chiang, E. Y., Walton, W. J. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 29, 8175-8178 (2011
115. Martins, T. B., et al. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int. Immunol. 20, 445-452 (2008
116. Tandon, R., et al.Revisiting the pathogenesis of rheumatic fever and carditis. Nat. Rev. Cardiol. 10, 171-177 (2013
117. Dinkla, K., et al. Streptococcus pyogenes recruits collagen via surface-bound fibronectin: A novel colonization and immune evasion mechanism. Mol. Microbiol. 47, 861-869 (2003
118. Lukomski, S., et al. Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect. Immun. 68, 6542-6553 (2000
119. Lukomski, S., et al. Identification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: Control of production at the level of translation. Infect. Immun. 69, 1729-1738 (2001
120. Galvin, J. E., et al. Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am. J. Pathol. 160, 297-306 (2002
121. Chopra, P., Narula, J., Kumar, A. S., Sachdeva, S., Bhatia, M. L. Immunohistochemical characterisation of Aschoff nodules and endomyocardial inflammatory infiltrates in left atrial appendages from patients with chronic rheumatic heart disease. Int. J. Cardiol. 20, 99-105 (1988
122. Chopra, P., Narula, J. P. Scanning electron microscope features of rheumatic vegetations in acute rheumatic carditis. Int. J. Cardiol. 30, 109-112 (1991
123. Roberts, S., et al. Immune mechanisms in rheumatic carditis: Focus on valvular endothelium. J. Infect. Dis. 183, 507-511 (2001
124. Aschoff, L. Myocarditisfrage. Verh. Dtsch. Path. Ges. 8, 46-53 (1906
125. Martins, C. de O., et al. Distinct mitral valve proteomic profiles in rheumatic heart disease and myxomatous degeneration. Clin. Med. Insights Cardiol. 8, 79-86 (2014
126. Guilherme, L., et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int. Immunol. 12, 1063-1074 (2000
127. Guilherme, L., et al. Rheumatic heart disease: Proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am. J. Pathol. 165, 1583-1591 (2004
128. Dileepan, T., et al. Robust antigen specific Th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog. 7, e1002252 (2011
129. Pepper, M., et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11, 83-89 (2010
130. Wang, B., et al. Induction of TGF1 and TGF1-dependent predominant TH17 differentiation by group A streptococcal infection. Proc. Natl Acad. Sci. USA 107, 5937-5942 (2010
131. Bas, H. D., et al. A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease. J. Invest. Med. 62, 78-83 (2014
132. Weaver, C. T., Hatton, R. D., Mangan, P. R., Harrington, L. E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852 (2007
133. Peck, A., Mellins, E. D. Precarious balance: TH17 cells in host defense. Infect. Immun. 78, 32-38 (2010
134. Guilherme, L., et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 92, 415-420 (1995
135. Kirvan, C. A., Galvin, J. E., Hilt, S., Kosanke, S., Cunningham, M. W. Identification of streptococcal M-protein cardiopathogenic epitopes in experimental autoimmune valvulitis. J. Cardiovasc. Transl Res. 7, 172-181 (2013
136. Veasy, L. G., Tani, L. Y. A new look at acute rheumatic mitral regurgitation. Cardiol. Young 15, 568-577 (2005
137. Jones, T. D. The diagnosis of rheumatic fever. J. Am. Med. Assoc. 126, 481-484 (1944
138. [No authors listed.] Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 69, 204A-208A (1984
139. [No authors listed.] Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268, 2069-2073 (1992
140. [No authors listed.] Jones criteria (modified) for guidance in the diagnosis of rheumatic fever; report of the Committee on Standards and Criteria for programs of care. Circulation 13, 617-620 (1956
141. [No authors listed.] Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 32, 664-668 (1965
142. Australia (ARF/RHD Writing Group), National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand. Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease 2nd edn (Menzies School of Health Research, 2012
143. Veasy, L. G., Tani, L. Y., Hill, H. R. Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr. 124, 9-16 (1994
144. Veasy, L. G., et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N. Engl. J. Med. 316, 421-427 (1987
145. Vijayalakshmi, I., Vishnuprabhu, R. O., Chitra, N. The efficacy of echocardiographic criterions for the diagnosis of carditis in acute rheumatic fever. Cardiol. Young 18, 586-592 (2008
146. Narula, J., Kaplan, E. L. Echocardiographic diagnosis of rheumatic fever. Lancet 358, 2000 (2001
147. Abernethy, M., et al. Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust. N. Z. J. Med. 24, 530-535 (1994
148. Figueroa, F. E., et al. Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: Long term follow up of patients with subclinical disease. Heart 85, 407-410 (2001
149. Minich, L., Tani, L. Y., Pagotto, L. T. Doppler echocardiography distinguishes between physiologic and pathologic 'silent' mitral regurgitation in patients with rheumatic fever. Clin. Cardiol. 20, 924-926 (1997
150. Padmavati, S., Gupta, V. Reappraisal of the Jones criteria: The Indian experience. N. Z. Med. J. 101, 391-392 (1988
151. Pereira, B. A. F., et al. Jones Criteria and underdiagnosis of rheumatic fever. Indian J. Pediatr. 74, 117-121 (2007
152. National Heart Foundation of New Zealand & the Cardiac Society of Australia and New Zealand. Evidence-based, best practice New Zealand Guidelines for Rheumatic Fever 1. Diagnosis, Management and Secondary Prevention (National Heart Foundation of New Zealand, 2006
153. National Heart Foundation of Australia (RF/RHD Guideline Development Working Group) & the Cardiac Society of Australia and New Zealand. Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease in Australia-an Evidence-Based Review (National Heart Foundation of New Zealand, 2006
154. Okello, E., et al. Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda. Cardiovasc. J. Afr. 24, 80-85 (2013
155. Singh, P. I., Carapetis, J. R., Buadromo, E. M., Samberkar, P. N., Steer, A. C. The high burden of rheumatic heart disease found on autopsy in Fiji. Cardiol. Young 18, 62-69 (2008
156. Gordis, L., Lilienfeld, A., Rodriguez, R. Studies in the epidemiology and preventability of rheumatic fever. I. Demographic factors and the incidence of acute attacks. J. Chronic Dis. 21, 645-654 (1969
157. Glover, J. A. Milroy lectures on the incidence of rheumatic diseases. Lancet 215, 499-505 (1930
158. Salmond, C., Crampton, P., Atkinson, J. NZDep2006 Index of Deprivation (Department of Public Health, 2007
159. Kerdemelidis, M., Lennon, D. R., Arroll, B., Peat, B., Jarman, J. The primary prevention of rheumatic fever. J. Paediatr. Child Health 46, 534-548 (2010
160. Irlam, J., Mayosi, B. M., Engel, M., Gaziano, T. A. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: A cost-effectiveness analysis. Circul. Cardiovasc. Qual. Outcomes 6, 343-351 (2013
161. Lennon, D., Stewart, J., Farrell, E., Palmer, A., Mason, H. School-based prevention of acute rheumatic fever: A group randomized trial in New Zealand. Pediatr. Infect. Dis. J. 28, 787-794 (2009
162. LeMarechal, F., Martnot, A., Duhamel, A., Pruvost, I., Dubos, F. Streptococcal pharyngitis in children: A meta-analysis of clinical decision rules and their clinical variables. BMJ Open 3, e001482 (2013
163. Catanzaro, F. J., Rammelkamp, C. H. Jr & Chamovitz, R. Prevention of rheumatic fever by treatment of streptococcal infections. N. Engl. J. Med. 259, 53-57 (1958
164. Bass, J. W., Crast, F. W., Knowles, C. R., Onufer, C. N. Streptococcal pharyngitis in children. A comparison of four treatment schedules with intramuscular penicillin G benzathine. JAMA 235, 1112-1116 (1976
165. Lennon, D. R., Farrell, E., Martin, D. R., Stewart, J. M. Once-daily amoxicillin versus twice-daily penicillin V in group A-haemolytic streptococcal pharyngitis. Arch. Dis. Child 93, 474-478 (2008
166. Clegg, H. W., et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: A noninferiority trial. Pediatr. Infect. Dis. J. 25, 761-767 (2006
167. Parks, T., Smeesters, P. R., Steer, A. C. Streptococcal skin infection and rheumatic heart disease. Curr. Opin. Infect. Dis. 25, 145-153 (2012
168. Martin, D. R., Voss, L. M., Walker, S. J., Lennon, D. Acute rheumatic fever in Auckland, New Zealand: Spectrum of associated group A streptococci different from expected. Pediatr. Infect. Dis. J. 13, 264-269 (1994
169. Williamson, D. A., et al. M-protein analysis of Streptococcus pyogenes isolates associated with acute rheumatic fever in New Zealand. J. Clin. Microbiol. 53, 3618-3620 (2015
170. Manyemba, J., Mayosi, B. M. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 3, CD002227 (2002
171. Tompkins, D. G., Boxerbaum, B., Liebman, J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45, 543-551 (1972
172. Taranta, A. Factors influencing recurrent rheumatic fever. Annu. Rev. Med. 18, 159-172 (1967
173. Bland, E. F., Duckett Jones, T. Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood. Circulation 4, 836-843 (1951
174. Ash, R. Rheumatic infection in childhood; 15 to 20 year follow-up. Am. J. Dis. Child 76, 46-52 (1948
175. Wilson, M. G., Lubschez, R. Longevity in rheumatic fever; based on the experience of 1, 042 children observed over a period of 30 years. J. Am. Med. Assoc. 138, 794-798 (1948
176. Lue, H. C., Wu, M. H., Wang, J. K., Wu, F. F., Wu, Y. N. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J. Pediatr. 125, 812-816 (1994
177. Spinetto, H., Lennon, D., Horsburgh, M. Rheumatic fever recurrence prevention: A nurse-led programme of 28-day penicillin in an area of high endemnicity. J. Paediatr. Child Health 47, 228-234 (2011
178. Tubridy-Clark, M., Carapetis, J. R. Subclinical carditis in rheumatic fever: A systematic review. Int. J. Cardiol. 119, 54-58 (2007
179. Araujo, F. D., Goulart, E. M., Meira, Z. M. Prognostic value of clinical and Doppler echocardiographic findings in children and adolescents with significant rheumatic valvular disease. Ann. Pediatr. Cardiol. 5, 120-126 (2012
180. Pekpak, E., et al. Rheumatic silent carditis: Echocardiographic diagnosis and prognosis of long-term follow up. Pediatr. Int. 55, 685-689 (2013
181. Remenyi, B., et al. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat. Rev. Cardiol. 10, 284-292 (2013
182. Pelajo, C. F., Lopez-Benitez, J. M., Torres, J. M., de Oliveira, S. K. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr. Rheumatol. Online J. 8, 22 (2010
183. Tadele, H., Mekonnen, W., Tefera, E. Rheumatic mitral stenosis in children: More accelerated course in sub-Saharan patients. BMC Cardiovasc. Disord. 13, 95 (2013
184. Heart Foundation of New Zealand. New Zealand guidelines for rheumatic fever: Diagnosis, management and secondary prevention of acute rheumatic fever and rheumatic heart disease: 2014 update. Heart Foundation of New Zealand [online], http://www.heartfoundation.org.nz/uploads/HF2227A-Rheumatic-Fever-Guideline-v3.pdf (2014
185. Nishimura, R. A., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129, e521-e643 (2014
186. Saxena, A., et al. Prevalence and outcome of subclinical rheumatic heart disease in India: The RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart 97, 2018-2022 (2011
187. Webb, R. H., et al. Optimising echocardiographic screening for rheumatic heart disease in New Zealand: Not all valve disease is rheumatic. Cardiol. Young 21, 436-443 (2011
188. Paar, J. A., et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am. J. Cardiol. 105, 1809-1814 (2010
189. Bhaya, M., Panwar, S., Beniwal, R., Panwar, R. B. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography 27, 448-453 (2010
190. Carapetis, J. R., et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat. Clin. Pract. Cardiovasc. Med. 5, 411-417 (2008
191. Marijon, E., et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470-476 (2007
192. Beaton, A., et al. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation 125, 3127-3132 (2012
193. Roberts, K., Colquhoun, S., Steer, A., Remenyi, B., Carapetis, J. Screening for rheumatic heart disease: Current approaches and controversies. Nat. Rev. Cardiol. 10, 49-58 (2013
194. Miranda, L. P., Camargos, P. A., Torres, R. M., Meira, Z. M. Prevalence of rheumatic heart disease in a public school of Belo Horizonte. Arq. Bras. Cardiol. 103, 89-97 (2014
195. Roberts, K. V., Brown, A. D., Maguire, G. P., Atkinson, D. N., Carapetis, J. R. Utility of auscultatory screening for detecting rheumatic heart disease in high-risk children in Australia's Northern Territory. Med. J. Aust. 199, 196-199 (2013
196. Zuhlke, L., Mayosi, B. M. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr. Cardiol. Rep. 15, 343 (2013
197. Remenyi, B., et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat. Rev. Cardiol. 9, 297-309 (2012
198. Roberts, K., et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation 129, 1953-1961 (2014
199. Beaton, A., et al. The utility of handheld echocardiography for early diagnosis of rheumatic heart disease. J. Am. Soc. Echocardiogr. 27, 42-49 (2014
200. Beaton, A., et al. Utility of handheld echocardiography for early rheumatic heart disease diagnosis: A field study. Eur. Heart J. Cardiovasc. Imaging 16, 475-482 (2015
201. Tani, L. Y. Echocardiographic screening for rheumatic heart disease. Circulation 129, 1912-1913 (2014
202. Colquhoun, S. M., et al. Echocardiographic screening in a resource poor setting: Borderline rheumatic heart disease could be a normal variant. Int. J. Cardiol. 173, 284-289 (2014
203. Beaton, A., et al. Latent rheumatic heart disease: Outcomes 2 years after echocardiographic detection. Pediatr. Cardiol. 35, 1259-1267 (2014
204. Bhaya, M., Beniwal, R., Panwar, S., Panwar, R. B. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 28, 929-933 (2011
205. Colquhoun, S. M., et al. Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji-a novel approach in a resource-poor setting. Cardiol. Young 23, 546-552 (2013
206. Kane, A., et al. Echocardiographic screening for rheumatic heart disease: Age matters. Int. J. Cardiol. 168, 888-891 (2013
207. Manji, R. A., et al. Cost-effectiveness analysis of rheumatic heart disease prevention strategies. Expert Rev. Pharmacoecon. Outcomes Res. 13, 715-724 (2013
208. Catanzaro, F. J., et al. The role of the streptococcus in the pathogenesis of rheumatic fever. Am. J. Med. 17, 749-756 (1954
209. New Zealand Heart Foundation. New Zealand guidelines for rheumatic fever 1: Diagnosis, management and secondary prevention. Heart Foundation of New Zealand [online], http://www.waikatodhb.health.nz/assets/for-health-professionals/Primary-care-management-guidelines/Guidelines-for-Rheumatic-Fever-1-Diagnosis-Management-and-Secondary-Prevention.pdf (2006
210. Carter, M. E., Bywaters, E. G., Thomas, G. T. Rheumatic fever treated with penicillin in bactericidal dosage for six weeks. Report of a small controlled trial. Br. Med. J. 1, 965-967 (1962
211. Mortimer, E. A. Jr, et al. The effect of penicillin on acute rheumatic fever and valvular heart disease. N. Engl. J. Med. 260, 101-112 (1959
212. Markowitz, M., Gordis, L. Rheumatic fever. Major Probl. Clin. Pediatr. 11, 1-309 (1972
213. Albert, D. A., Harel, L., Karrison, T. The treatment of rheumatic carditis: A review and meta-analysis. Medicine (Baltimore) 74, 1-12 (1995
214. Cilliers, A., Manyemba, J., Adler, A. J., Saloojee, H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst. Rev. 6, CD003176 (2012
215. Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. Treatment of acute rheumatic fever in children a co-operative clinical trial of A.C.T.H., cortisone and aspirin. Circulation 11, 343-377 (1955
216. Voss, L. M., et al. Intravenous immunoglobulin in acute rheumatic fever: A randomized controlled trial. Circulation 103, 401-406 (2001
217. Azevedo, P. M., Pereira, R. R., Guilherme, L. Understanding rheumatic fever. Rheumatol. Int. 32, 1113-1120 (2012
218. Nishimura, R. A., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, e57-e185 (2014
219. Anderson, Y., Wilson, N., Nicholson, R., Finucane, K. Fulminant mitral regurgitation due to ruptured chordae tendinae in acute rheumatic fever. J. Paediatr. Child Health 44, 134-137 (2008
220. Finucane, K., Wilson, N. Priorities in cardiac surgery for rheumatic heart disease. Glob. Heart 8, 213-220 (2013
221. Cardoso, F., Vargas, A. P., Oliveira, L. D., Guerra, A. A., Amaral, S. V. Persistent Sydenham's chorea. Mov. Disord.14, 805-807 (1999
222. Genel, F., Arslanoglu, S., Uran, N., Saylan, B. Sydenham's chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 24, 73-76 (2002
223. Daoud, A. S., Zaki, M., Shakir, R., al-Saleh, Q. Effectiveness of sodium valproate in the treatment of Sydenham's chorea. Neurology 40, 1140-1141 (1990
224. Pena, J., Mora, E., Cardozo, J., Molina, O., Montiel, C. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: Clinical follow-up of 18 patients. Arq. Neuropsiquiatr. 60, 374-377 (2002
225. Hashkes, P. J., et al. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: A randomized trial. J. Pediatr. 143, 399-401 (2003
226. Uziel, Y., et al. The use of naproxen in the treatment of children with rheumatic fever. J. Pediatr. 137, 269-271 (2000
227. Carapetis, J. R., McDonald, M., Wilson, N. J. Acute rheumatic fever. Lancet 366, 155-168 (2005
228. World Health Organization. Report of a WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease (WHO, 2001
229. Wilson, N., Voss, L. M., Neutze, J. M. in Proceedings of the Second World Congress of Pediatric Cardiology and Cardiacsurgery (eds Imai, Y., Momma, K.) 971-972 (Futura Publishing Co., 1998
230. Walsh, W. F. Medical management of chronic rheumatic heart disease. Heart Lung Circ. 19, 289-294 (2010
231. Nishimura, R. A., et al. ACC/AHA 2008 Guideline update on valvular heart disease: Focused update on infective endocarditis: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons. J. Am. Coll. Cardiol 52, 676-685 (2008)
232. Cheung, M. M., Sullivan, I. D., de Leval, M. R., Tsang, V. T., Redington, A. N. Optimal timing of the Ross procedure in the management of chronic aortic incompetence in the young. Cardiol. Young 13, 253-257 (2003
233. Gentles, T. L., et al. Normalized end-systolic volume and pre-load reserve predict ventricular dysfunction following surgery for aortic regurgitation independent of body size. JACC Cardiovasc. Imaging 5, 626-633 (2012
234. Remenyi, B., et al. Improved long-term survival for rheumatic mitral valve repair compared to replacement in the young. World J. Pediatr. Congenit. Heart Surg. 4, 155-164 (2013
235. Gentles, T. L., Finucane, A. K., Remenyi, B., Kerr, A. R., Wilson, N. J. Ventricular function before and after surgery for isolated and combined regurgitation in the young. Ann. Thorac. Surg. 100, 1383-1389 (2015
236. Enriquez-Sarano, M., Akins, C. W., Vahanian, A. Mitral regurgitation. Lancet 373, 1382-1394 (2009
237. DiBardino, D. J., et al. Four decades of experience with mitral valve repair: Analysis of differential indications, technical evolution, long-term outcome. J. Thorac. Cardiovasc. Surg. 139, 76-83; discussion 83-74 (2010
238. Antunes, M. J., Magalhaes, M. P., Colsen, P. R., Kinsley, R. H. Valvuloplasty for rheumatic mitral valve disease. A surgical challenge. J. Thorac. Cardiovasc. Surg. 94, 44-56 (1987
239. Sadler, L., et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 107, 245-253 (2000
240. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): Position paper from the World Health Organization. Soc. Sci. Med. 41, 1403-1409 (1995
241. do Nascimento Moraes, A. Health related quality of life in children with rheumatic heart diseases: Reliablityof the Brazilian version of the pediatric quality of life inventory cardiac module scale. Health Qual. Life Outcomes 11, 198 (2013
242. Arafa, M., Zaher, S., El-Dowaty, A., Moneeb, D. Quality of life among parents of children with heart disease. Health Qual. Life Outcomes 6, 91 (2008
243. Essaway, M., Bahgat, Z., Kassem, H. Health-related quality of life of school-aged children with rheumatic fever. J. Egypt Publ. Health Associ. 85, 205-222 (2010
244. Wark, E., Hodder, Y., Woods, C., Maguie, G. Patient and health-care impact of a pilot rheumatic heart disease screening program. J. Paediatr. Child Health 49, 297-302 (2013
245. Pilgrim, T., et al. Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among school children in Nepal. BMJ Open 2, e001320 (2012
246. Koech, M., Ngeno, T. Perception of parents whose children have rheumatic heart disease at a referral hospital, Kenya. Bas. Res. J. Med. Clin. Sci. 3, 67-73 (2014
247. Atnafe, L. The Experience of Married Women with Rheumatic Heart Disease. Thesis, Addis Ababa University (2011
248. Harrington, Z., Thomas, D., Currie, B., Bulkanhawuy, J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med. J. Aust. 184, 514-517 (2006
249. Petricca, K., Mamo, Y., Haileamlk, A., Seid, E., Parry, E. Barriers to effective follow-up treatment for rheumatic heart disease in Jimma, Ethiopia: A grounded theory analysis of the patient experience. Ethiopian J. Health Sci. 19, 39-44 (2009
250. Johnson, T. D., et al. The 5 × 5 path towards rheumatic heart disease control: Outcomes from the third rheumatic heart disease forum. Glob. Heart 10, 75-78 (2014
251. Guilherme, L., Kalil, J. Rheumatic fever and rheumatic heart disease: Cellular mechanisms leading autoimmune reactivity and disease. J. Clin. Immunol. 30, 17-23 (2010
252. Mayosi, B., et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S. Afr. Med. J. 96, 246 (2006
253. Karthikeyan, G., et al. Rationale and design of a Global Rheumatic Heart Disease Registry: The REMEDY study. Am. Heart J. 163, 535-540 (2012
254. Ministry of Health and Family Welfare & Government of India Rashtriya Bal Swasthya Karyakram. Child Health Screening and Early Intervention Services under NRHM. National Health Mission [online], http://nrhm.gov.in/images/pdf/programmes/RBSK/Resource-Documents/RBSK%20Resource% 20Material.pdf (2013
255. Nishimura, R. A., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, 2438-2488 (2014
256. Moran, M., et al. Neglected disease research and development: How much are we really spending PLoS Med. 6, e30 (2009
257. Dale, J. B., et al. Group A streptococcal vaccines: Paving a path for accelerated development. Vaccine 31, B216-B222 (2013
258. Guerino, M. T., et al. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate. Vaccine 29, 8250-8256 (2011
259. Engel, M. E., Stander, R., Vogel, J., Adeyemo, A. A., Mayosi, B. M. Genetic susceptibility to acute rheumatic fever: A systematic review and meta-analysis of twin studies. PLoS ONE 6, e25326 (2011
260. Fae, K. C., et al. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J. Autoimmun. 31, 136-141 (2008
261. Gao, G., et al. Identification of altered plasma proteins by proteomic study in valvular heart diseases and the potential clinical significance. PLoS ONE 8, e72111 (2013
262. Ramakrishnan, S., et al. Prevalence of rheumatic heart disease: Has it declined in India Natl Med. J. India 22, 72-74 (2009